abstract |
The present invention relates to methods of treating cancer in mammals and combinations of agents useful for such treatment. In particular, the method relates to a cancer therapy comprising administering an erb family inhibitor and a PI3K and / or Akt inhibitor to a mammal affected by cancer. [Selection figure] None |